News

Understanding Eli Lilly's Unusual Options Activity Today

Understanding Eli Lilly's Unusual Options Activity Today

Eli Lilly's Options Activity Analysis

Eli Lilly has recently caught the attention of investors as distinctive bearish activity has been observed among financial giants. By analyzing options history for Eli Lilly (NYSE: LLY), we discovered a total of 84 unusual trades that reflect diverse market sentiments.

Current Market Sentiment

In examining this trading activity, it's evident that 27% of traders exhibited a bullish outlook, while a significant 51% leaned bearish. The trades consisted of 26 puts valued at $2,090,541, and 58 calls worth an impressive $10,418,102.

Price Movement Expectations

Considering the trading volume and open interest on these options, it appears that major investors are anticipating Eli Lilly's price to fluctuate within the ranges of $520.0 to $1400.0 over the last three months. This range provides a comprehensive view of potential price actions that traders are keenly observing.

Volume and Open Interest Insights

Monitoring both volume and open interest is a reliable approach for conducting due diligence on Eli Lilly's stock. Analyzing this data facilitates the tracking of liquidity and interest regarding the options corresponding to specific strike prices.

Recent Activity Overview

In the past 30 days, the volume and open interest surrounding Eli Lilly’s options have seen notable variations within the established strike price range of $520.0 to $1400.0. The following sections provide valuable insights into this trading landscape.

Summary of Options Activity

Here is a concise summary of options activity for Eli Lilly:

  • LLY Call: A striking example indicates a trade executed with a sentiment categorized as neutral, where the traded price was noted at $248.0 against an ask of $253.0.
  • Another notable bearish call revealed an executed trade priced at $152.0 amidst a backdrop of fluctuating market conditions.
  • A more bullish scenario for $164.24 was noted, aligning with a target indicated by an average of ratings from experts, optimizing the stock evaluation.

About Eli Lilly

Eli Lilly is a leading pharmaceutical company specializing in areas such as neuroscience, cancer, cardiometabolic, and immunology. The company’s product lineup includes Verzenio for oncology, Mounjaro, Jardiance, and Trulicity for managing cardiometabolic disorders, alongside Taltz and Olumiant for immunological treatments.

Current Stock Performance

The company’s current stock performance indicates a trading volume of 1,643,178, showing a decrease of 2.73% at $1074.19. The RSI indicators are hinting that the stock might be experiencing an overbought status.

Analysts’ Perspectives on Eli Lilly

Several experts have been vocal regarding Eli Lilly’s stock opportunities. Recently, five analysts have released their ratings with an average target price of $1195.8. Here’s some insight:

  • Citigroup maintains a Buy rating, targeting a price of $1500.
  • Leerink Partners upgraded their stance to Outperform, adjusting their target to $1104.
  • BMO Capital sustains an Outperform rating with a $1100 target.
  • Morgan Stanley keeps an Overweight rating, eyes a price of $1290.
  • Cantor Fitzgerald holds an Overweight rating, targeting $985.

Risk Considerations in Options Trading

When it comes to options trading, it is essential to recognize that they pose greater risks compared to straightforward stock trading. However, they also offer higher profit potentials. To navigate this landscape, traders should focus on education, scaling their involvement in trades, and utilizing multiple indicators while closely monitoring the market trends.

Stay Updated

If you are interested in keeping abreast of the latest in options trading for Eli Lilly, there are real-time options trades alerts available through dedicated platforms, ensuring you're well-informed in this dynamic environment.

Frequently Asked Questions

What unusual options activity has been observed for Eli Lilly?

Recent analysis shows 84 notable trades, with a significant portion being bearish in nature.

What are the expectations regarding Eli Lilly's stock price?

Major investors are targeting a price range between $520.0 to $1400.0 in the coming months.

What do the analysts say about Eli Lilly's stock?

Analysts have an average target price of $1195.8 with several maintaining bullish stances.

How much is Eli Lilly's stock trading currently?

As of now, Eli Lilly's stock is trading at $1074.19 with a noted decrease of 2.73%.

What strategies are recommended for options trading?

Educating oneself, managing risk, and closely following market trends are vital for success in options trading.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 4

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 3

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 0

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 0

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 0

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 2

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 3

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 2

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 0

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 0

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Movements: Microsoft and Nvidia Lead Gains Amid Losses

Updated Category News Views 187

Overview of Stock Market Movements US stock futures exhibited a stable trend recently as investors remained vigilant in anticipation of upcoming employment data and insights from the latest Federal Reserve policy-setting meeting. Key Market Losers Exxon Mobil's Decline Exxon Mobil (NYSE: XOM) saw its stock drop by 0.7%, following a warning concerning a decline in oil...

Continue Reading
Central Banks Face New Stability Risks from AI Technologies

Updated Category News Views 184

Central Banks Must Adapt to Evolving Technological Risks In recent discussions, Bank of Japan Governor Kazuo Ueda has highlighted significant concerns regarding the intersection of artificial intelligence (AI) and financial stability. As central banks navigate the complexities of a rapidly changing financial landscape, Ueda's insights serve as a crucial reminder of the...

Continue Reading
H2O America Delivers Strong Q3 Results with Continued Growth

Updated Category News Views 254

H2O America Reports Impressive Third Quarter Results H2O America (NASDAQ: HTO) has announced its financial results for the third quarter of 2025, showcasing remarkable growth and strategic advances in the water utility sector. The reported diluted EPS reached $1.27, reflecting an 8% increase in adjusted diluted EPS from the previous year. Key Financial Highlights As part...

Continue Reading
Sesame Software Achieves SOC 2 Compliance, Ensuring Data Security for 2025

Updated Category News Views 174

Sesame Software Milestone: Achieving SOC 2 Level 1 Compliance Sesame Software, a leader in innovative data integration and backup solutions, proudly announces its successful achievement of SOC 2 Level 1 compliance. This milestone is a testament to the company's unwavering commitment to protecting customer data and maintaining the highest standards of information security...

Continue Reading
Bio-Techne Introduces Innovative Protein Detection Program

Updated Category News Views 248

Bio-Techne Unveils Groundbreaking Protein Proximity Program New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues Today, Bio-Techne Corporation (NASDAQ: TECH), a prominent name in the life science tools sector, has revealed an exciting Early Access Program. This initiative focuses on a...

Continue Reading